LGALS3 and colonic neoplasm: In conclusion, we show for the first time that galectin-3 silencing sensitizes MDR cells to epirubicin by inhibiting P-gp and MRPs and the activation of the mitochondrial apoptosis pathway through modulation of the β-catenin/GSK-3β pathway in human colon cancer cells.